View drug registration information details.
| Items | Registration information |
|---|
| ID | 915 |
|---|
| No | 915 |
|---|
| Brand Name | ERDAMAKS |
|---|
| Ingredients | ERDAFITINIB 4 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 56 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA THAT HAS SUSCEPTIBLE FGFR3 OR FGFR2 GENETIC ALTERATION AND PROGRESSED DURING OR FOLLOWING AT LEAST ONE LINE OF PRIOR PLATINUM CONTAINING CHEMOTHERAPY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | ROUND, PLAT, YELLOW FILM COATED TABLET |
|---|
| Note | |
|---|
| License Owner | FACTORY NO.2 |
|---|
| Manufacturer | FACTORY NO. 2 |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 02 L 1293/25 |
|---|
| FDD Registration Date | 2025-02-20 |
|---|
| Expiry Date | 2030-02-19 |
|---|
Back to drug list
|
